Swedbank AB Sells 570 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Swedbank AB trimmed its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 2.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 19,390 shares of the medical instruments supplier’s stock after selling 570 shares during the quarter. Swedbank AB’s holdings in Mettler-Toledo International were worth $23,727,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in MTD. State Street Corp increased its stake in shares of Mettler-Toledo International by 1.0% in the 3rd quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock worth $1,431,693,000 after purchasing an additional 9,009 shares in the last quarter. Geode Capital Management LLC increased its position in Mettler-Toledo International by 0.8% in the third quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock worth $818,906,000 after buying an additional 4,166 shares in the last quarter. Barclays PLC raised its stake in shares of Mettler-Toledo International by 8.3% in the third quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock worth $384,822,000 after buying an additional 19,609 shares during the period. JPMorgan Chase & Co. lifted its position in shares of Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after buying an additional 28,478 shares in the last quarter. Finally, Loomis Sayles & Co. L P grew its stake in shares of Mettler-Toledo International by 1.8% during the 3rd quarter. Loomis Sayles & Co. L P now owns 209,902 shares of the medical instruments supplier’s stock valued at $314,790,000 after acquiring an additional 3,644 shares during the period. 95.07% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the sale, the director now directly owns 240 shares of the company’s stock, valued at $314,820. The trade was a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Gerry Keller sold 140 shares of the firm’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the sale, the insider now directly owns 6 shares of the company’s stock, valued at $7,524.54. The trade was a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Mettler-Toledo International Price Performance

NYSE MTD opened at $1,362.71 on Friday. Mettler-Toledo International Inc. has a 1-year low of $1,133.46 and a 1-year high of $1,546.93. The business has a 50 day simple moving average of $1,260.70 and a two-hundred day simple moving average of $1,343.47. The stock has a market capitalization of $28.75 billion, a PE ratio of 36.74, a P/E/G ratio of 4.19 and a beta of 1.12.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. The firm had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. On average, analysts anticipate that Mettler-Toledo International Inc. will post 40.42 EPS for the current fiscal year.

Analysts Set New Price Targets

MTD has been the subject of a number of recent analyst reports. Robert W. Baird dropped their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and increased their price target for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Evercore ISI upgraded Mettler-Toledo International from an “in-line” rating to an “outperform” rating and boosted their price objective for the company from $1,375.00 to $1,450.00 in a research report on Thursday, January 2nd. Wolfe Research initiated coverage on Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating for the company. Finally, Wells Fargo & Company lowered their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. One analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $1,351.25.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.